Walleye Capital LLC Pacific Biosciences Of California, Inc. Call Options Transaction History

Walleye Capital LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$1.2 - $2.17 $254,760 - $460,691	-212,300 Reduced 98.15%	4,000 $6,000
Q2 2024 Aug 14, 2024	SELL	$1.36 - $3.65 $57,120 - $153,300	-42,000 Reduced 16.26%	216,300 $296,000
Q1 2024 May 15, 2024	BUY	$3.52 - $9.59 $796,224 - $2.17 Million	226,200 Added 704.67%	258,300 $968,000
Q4 2023 Feb 14, 2024	SELL	$5.97 - $10.36 $23,283 - $40,404	-3,900 Reduced 10.83%	32,100 $314,000
Q3 2023 Nov 14, 2023	SELL	$8.23 - $13.93 $169,538 - $286,958	-20,600 Reduced 36.4%	36,000 $300,000
Q2 2023 Aug 14, 2023	BUY	$9.97 - $14.05 $346,956 - $488,940	34,800 Added 159.63%	56,600 $752,000
Q1 2023 May 15, 2023	BUY	$7.94 - $12.02 $173,092 - $262,036	21,800 New	21,800 $252,000

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $443M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.